NCT06975605 2025-11-18
Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.
GRIN Therapeutics, Inc.
Phase 1 Completed
GRIN Therapeutics, Inc.
Neurim Pharmaceuticals Ltd.
The University of Texas Health Science Center, Houston